Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Loss Narrows At MedImmune; Serono's Profits Still Climbing

Oct. 24, 2003

By Aaron Lorenzo

Loss Narrows At MedImmune; Serono's Profits Still Climbing

Oct. 24, 2003

By Aaron Lorenzo

AaiPharma Purchases Four Pain Products From Elan For $100M

Oct. 23, 2003

By Aaron Lorenzo

AaiPharma Purchases Four Pain Products From Elan For $100M

Oct. 23, 2003

By Aaron Lorenzo

Biospect Raises $27M In Series A Round; Diagnostics First Focus

Oct. 22, 2003

By Aaron Lorenzo

Biospect Raises $27M In Series A Round; Diagnostics First Focus

Oct. 22, 2003

By Aaron Lorenzo

Next Up: Renovis Steps Into Growing Biotech IPO Queue

Oct. 21, 2003

By Aaron Lorenzo

Next Up: Renovis Steps Into Growing Biotech IPO Queue

Oct. 21, 2003

By Aaron Lorenzo

FDA Signs Off On Namenda For Moderate To Severe Alzheimer's

Oct. 20, 2003

By Aaron Lorenzo

Patients suffering from a seemingly hopeless affliction, and those around them, might gain a glimmer of hope on news of the FDA's approval of Namenda (memantine HCL) for Alzheimer's disease. (BioWorld Today)

FDA Signs Off On Namenda For Moderate To Severe Alzheimer's

Oct. 20, 2003

By Aaron Lorenzo

Patients suffering from a seemingly hopeless affliction, and those around them, might gain a glimmer of hope on news of the FDA's approval of Namenda (memantine HCL) for Alzheimer's disease. (BioWorld Today)